Number of the records: 1
apolipoproteíny B
SYS d001055 LBL 00000cz--a2200000n--4500 005 20250606213316.7 008 920525|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D10.532.091.300 065 $a D12.776.070.400.300 065 $a D12.776.521.120.300 066 $a 01 $c 03 150 $a apolipoproteíny B $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a Apo-B $2 eng 450 $w v $a apo B $2 slo 450 $w v $a apoproteín B $2 slo 550 $7 sllk_us_auth*d000012 $Y Abetalipoproteinemia $w p $a abetalipoproteinémia 665 $a 85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93 $2 eng 665 $a Apolipoproteins (1977-1984) $2 eng 680 9-
$i Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. $2 eng 750 -2
$a Apolipoproteins B $2 eng 980 $x M
Number of the records: 1